NCT05156736View on ClinicalTrials.gov

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

February 29, 2028

Study Completion Date

November 30, 2028

Conditions
Atherosclerotic PlaqueDiabetes Mellitus, Type 2HypertensionStroke
Trial Locations (1)

74500

RECRUITING

Tabba Heart Institute, Karachi

Sponsors

Collaborators (1)

Getz Pharma
All Listed Sponsors
collaborator

Getz Pharma

INDUSTRY

lead

Tabba Heart Institute

OTHER

NCT05156736 - Pakistan Study of Premature Coronary Atherosclerosis in Young Adults | Biotech Hunter | Biotech Hunter